vasa denticity has scheduled an earnings conference call for June 5, 2026, to review the financial results for the quarter and financial year ended March 31, 2026. The session will provide insights into the company's operational performance and financial health for the period. No unpublished price sensitive information (UPSI) will be discussed during the proceedings.

The conference call is scheduled for Friday, June 5, 2026, from 11:00 A.M. to 1:00 P.M. IST. The disclosure is made pursuant to Regulation 46(2) of the SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015. The information regarding the call is available on the company's official website.

The meeting will be accessible via Google Meet, allowing stakeholders to join remotely. Management representatives, including the Chairman & Managing Director and Whole-Time Director, will lead the discussion.

Conference Call Details

Management Representatives

The earnings call will feature key members of the management team:

• Dr. Vikas Agarwal (Chairman & Managing Director)
• Mr. Sandeep Agarwal (Whole-Time Director)
• Mr. Sunil Gupta (AVP-Finance)
• Mr. Rajat Anand (AVP-SupplyChain)
• Mr. Akash Bairwa (General Manager-Supply)
• Mr. Mukesh (General Manager-Warehousing)

Vasa Denticity Limited has informed the National Stock Exchange of India Ltd that it and IDS Denmed Private Limited have mutually decided not to proceed with their proposed acquisition. The disclosure was made on May 08, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and follows the company's earlier intimation dated August 07, 2025 regarding the proposed transaction.

Reasons for Calling Off the Acquisition

According to the regulatory disclosure, both parties concluded during the diligence process that the two businesses are at meaningfully different stages of operating and digital maturity. The company stated that the integration effort required to bring them together would absorb management bandwidth and operational complexity disproportionate to the value it would create in the near term. The decision was described as mutual, and the company confirmed that the relationship between the two organisations remains cordial.

Key details of the development are summarised below:

Strategic Focus Remains on Core Business

Vasa Denticity stated that this outcome is fully consistent with its focus on dentalkart.com, which it described as the core of its business. Management indicated it has consciously decided to direct its energy, in the near term, toward strengthening this core through the following priorities:

• Deeper automation to improve operational efficiency
• A lean operating model to support disciplined profitability
• Continued expansion of private label brands to scale revenue

The company characterised the current fiscal year as one of deep operating focus rather than inorganic expansion, noting that its capital allocation reflects this conviction.

Potential Collaboration as Independent Entities

Despite calling off the acquisition, Vasa Denticity noted that it continues to see areas of potential collaboration with IDS Denmed. The company stated its intention to explore these opportunities as independent entities, where value can be captured without integration overhead.

The company also indicated that its detailed strategic outlook, performance, and forward commentary will be shared as part of its upcoming results announcement and investor interaction, where management will be available to address questions. The disclosure was signed by Nidhi, Company Secretary and Compliance Officer (M.No. A74591), on behalf of Vasa Denticity Limited.